Scholar Rock will present new Phase 3 SAPPHIRE trial data on apitegromab at the 2025 MDA conference, highlighting efficacy ...

Mid-cap stocks have the best odds of scaling into $100 billion corporations thanks to their tested business models and large addressable markets. But the many opportunities in front of them attract ...

Changes are coming to Mega Millions in 2025 that make it easier to win a non-jackpot prize, although these shifts involve one ...

Chronic spontaneous urticaria is an idiopathic syndrome defined by recurring itch, hives, or angioedema (or a combination of ...

The odds are the ratio between the amount wagered by the bookmaker ... In terms of projected winnings, it is fairly simple to read odds – simply put, the number on the right of the fraction ...

U.S. stocks advanced on Wednesday as cooler-than-expected inflation data helped stanch a sharp selloff, while the escalation ...

My current strategy combines dividend growth investing with Big Picture research. Check out my take on the 10 Rules of Successful Investing by Bob Farrell.

Bitcoin price rose 3% in the last 24 hours, reclaiming territories above $83,700 after forming a local bottom around $76,000 ...

In this randomized controlled trial, among patients with persistent chylomicronemia, it was found that plozasiran more ...

We use our proprietary models to rate stocks quantitatively and qualitatively. Read here for an analysis of our top picks in ...